KIF15 and pachyonychia congenita: Meanwhile, the KIF15 acetylation level was significantly upregulated in PC treated with SIRTs and HDACs inhibitors (TSA and NAM) (Supplementary Fig. S6C), but the integrin β1/FAK pathway was inhibited (Supplementary Fig. S6E).